Search ASX code:
Generic filters

Untitled design (1)

SETTING FIRE TO YOUR FINANCES?

TAKE CONTROL OF YOUR MONEY TODAY WITH OUR FREE ONLINE COURSE

TAKE CONTROL OF YOUR MONEY TODAY WITH OUR
FREE ONLINE COURSE

SETTING FIRE TO YOUR FINANCES?

TAKE CONTROL OF YOUR MONEY TODAY WITH OUR FREE ONLINE COURSE

CIMIC (ASX:CIM) to sell half of Thiess

CIMIC (ASX: CIM) has announced that it plans to sell half of Thiess.

CIMIC is one of Australia’s largest engineering businesses, it used to be called Leighton. It is involved in construction, mining, services and public private partnerships. It’s involved across the lifecycle of assets, infrastructure and resource projects.

CIMIC to sell Thiess?

Thiess is the world’s largest mining services provider according to CIMIC.

CIMIC announced this morning that it has signed an exclusivity agreement and is in advanced negotiations with funds advised by Elliot Advisers.

Why is CIMIC thinking about doing this?

CIMIC said that the introduction of an equity partner in Thiess would capitalise on the “robust outlook” for the mining sector and provide capital for Thiess’ continued growth, while enabling CIMIC to maintain its strong balance sheet.

Management expect that the advanced negotiations will conclude in the coming weeks with a share purchase agreement that will require the usual approvals.

Summary

It’s an interesting move for CIMIC to sell half of one of its main divisions. Hopefully it gets a good price for the stake because it will be losing some earnings. CIMIC isn’t my type of business though, I’d rather buy a good growth share.

1 ASX Stock to Buy RIGHT NOW...

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or enter your email below. We'll send you the report.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or the button below. We'll email you the report.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Keep reading: